Days Inventory is also known as Days Sales of Inventory (DSI). MiMedx Group's Average Total Inventories for the
three
months ended in Dec. 2023 was $20.0 Mil. MiMedx Group's Cost of Goods Sold for the
three
months ended in Dec. 2023 was $13.8 Mil.
Hence, MiMedx Group's Days Inventory for the
three
months ended in Dec. 2023 was 132.14.
The historical rank and industry rank for MiMedx Group's Days Inventory or its related term are showing as below:
MDXG'
s Days Inventory Range Over the Past 10 Years
Min: 90.32 Med: 114.01 Max: 149.09
Current: 113.23
During the past 13 years, MiMedx Group's highest Days Inventory was 149.09. The lowest was 90.32. And the median was 114.01.
MDXG's Days Inventory is ranked better than 71.23% of 650
companies
in the Biotechnology industry
Industry Median: 191.745
vs MDXG: 113.23
MiMedx Group's Days Inventory
increased
from Dec. 2022 (86.24) to Dec. 2023 (132.14).
It might indicate that MiMedx Group's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
MiMedx Group's Inventory Turnover for the
three
months ended in Dec. 2023 was 0.69.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
MiMedx Group's Inventory-to-Revenue for the
three
months ended in Dec. 2023 was 0.23.
MiMedx Group Days Inventory Historical Data
The historical data trend for MiMedx Group's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of MiMedx Group's Days Inventory
For the Biotechnology subindustry, MiMedx Group's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MiMedx Group's Days Inventory Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, MiMedx Group's Days Inventory distribution charts can be found below:
* The bar in red indicates where MiMedx Group's Days Inventory falls into.
MiMedx Group Days Inventory Calculation
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
MiMedx Group's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MiMedx Group (NAS:MDXG) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
MiMedx Group's Inventory Turnover for the
three
months ended in Dec. 2023 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
MiMedx Group's Inventory to Revenue for the
three
months ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
MiMedx Group Days Inventory Related Terms
Thank you for viewing the detailed overview of MiMedx Group's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, MiMedx sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MDXG has been successfully added to your 